GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

canakinumab   Click here for help

GtoPdb Ligand ID: 6773

Synonyms: ACZ 885 | ACZ885 | Ilaris®
Approved drug Immunopharmacology Ligand
canakinumab is an approved drug (FDA (2009), EMA (2009))
Compound class: Antibody
Comment: Canakinumab targets interleukin-1β [1].
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Classification Click here for help
Compound class Antibody
Approved drug? Yes. US FDA (2009)  |  EU EMA (2009)
International Nonproprietary Names Click here for help
INN number INN
8836 canakinumab
Synonyms Click here for help
ACZ 885 | ACZ885 | Ilaris®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 244
Other databases
GtoPdb PubChem SID 178103379
PubChem SID 178103379
Search PubMed clinical trials canakinumab
Search PubMed titles canakinumab
Search PubMed titles/abstracts canakinumab
SynPHARM 78932 (in complex with interleukin 1 beta)
Wikipedia Canakinumab